Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 1,622 shares at $89.91 ($146K) on 2021-06-28, disclosed to the SEC on 2021-06-30.
Open-market sale of $146k BPMC by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.28 | 24 | $2K | 1.5% |
| 2 | $89.91 | 622 | $56K | 38.3% |
| 3 | $89.91 | 622 | $56K | 38.3% |
| 4 | $90.88 | 354 | $32K | 22.0% |
| Total | $90.11 avg | 1,622 | $146K | 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |